Group One Trading
OKUR

Group One Trading’s OnKure Therapeutics OKUR Stock Holding History

Group One Trading’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$1.66K – 7627
2024
Q1 		$1.66K Sell
100
-3,190
-97% -$52.6K ﹤0.01% 6527
2023
Q4 		$52.6K Buy
+3,290
New +$205K ﹤0.01% 5018

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Group One Trading's OKUR Position: Q1 2026 in Review

Group One Trading sold out of OnKure Therapeutics (OKUR) in Q1 2026, closing a stake of 56 shares — an estimated $162 sold.

Group One Trading first reported a position in OKUR in Q1 2024 and held it in 8 quarters. The position peaked at $12.6K in Q1 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Group One Trading reported no remaining OnKure Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 56 OnKure Therapeutics shares in Q1 2026, an estimated $162.
  • Group One Trading first reported a position in OnKure Therapeutics in Q1 2024 and held it in 8 quarters.
  • Group One Trading's OnKure Therapeutics position peaked at $12.6K in Q1 2024.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.